Does IBANDRONATE Cause Focal segmental glomerulosclerosis? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Focal segmental glomerulosclerosis have been filed in association with IBANDRONATE (Ibandronate Sodium). This represents 0.1% of all adverse event reports for IBANDRONATE.
9
Reports of Focal segmental glomerulosclerosis with IBANDRONATE
0.1%
of all IBANDRONATE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From IBANDRONATE?
Of the 9 reports, 2 (22.2%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBANDRONATE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does IBANDRONATE Cause?
Femur fracture (990)
Arthralgia (975)
Pain (779)
Pain in extremity (726)
Back pain (688)
Myalgia (623)
Diarrhoea (551)
Low turnover osteopathy (521)
Nausea (480)
Anxiety (456)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which IBANDRONATE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
IBANDRONATE vs IBANDRONIC ACID
IBANDRONATE vs IBERDOMIDE
IBANDRONATE vs IBREXAFUNGERP
IBANDRONATE vs IBRITUMOMAB TIUXETAN
IBANDRONATE vs IBRUTINIB